Issue 10, 2012

Synthesis and biological activity profile of novel 2-cinnamylidene-1,3-diones related to coruscanone A: promising new antileishmanial agents

Abstract

A series of 2-cinnamyliden-1,3-diones related to the natural product coruscanone A was prepared from simple commercially available precursors via Knoevenagel condensation, and evaluated for antifungal, antibacterial and antiparasitic activities. Most of the compounds tested displayed antifungal effects against opportunistic pathogen C. neoformans comparable to coruscanone A and its derivatives suggesting that the mechanism of action of this class of compounds would involve Michael addition of a nucleophilic site of the biological target on the styryl side chain instead of the previously proposed reaction at the cyclopentenedione ring. In addition, some showed good in vitro antileishmanial activity (L. donovani), one of the compounds being superior to pentamidine and comparable to amphotericin B.

Graphical abstract: Synthesis and biological activity profile of novel 2-cinnamylidene-1,3-diones related to coruscanone A: promising new antileishmanial agents

Supplementary files

Article information

Article type
Concise Article
Submitted
31 May 2012
Accepted
30 Jul 2012
First published
03 Aug 2012

Med. Chem. Commun., 2012,3, 1294-1298

Synthesis and biological activity profile of novel 2-cinnamylidene-1,3-diones related to coruscanone A: promising new antileishmanial agents

M. J. Riveira, B. L. Tekwani, G. R. Labadie and M. P. Mischne, Med. Chem. Commun., 2012, 3, 1294 DOI: 10.1039/C2MD20143G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements